Client of a consultant lobbyist
Voyageur Pharmaceuticals Ltd.
- Meetings this Parliament
- 5
- With MPs
- 0
- Since Nov 2021
- 5
- Active registrations
- 0
Most recent reported meeting: Mar 4, 2026.
Lobbying by Voyageur Pharmaceuticals Ltd.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Voyageur Pharmaceuticals Ltd. has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Brian Senio · Consultant
- Benoit Leduc · Manager, Life Sciences Directorate, Innovation, Science and Economic Development Canada (ISED)
- Shanon McAreavy · Senior Business Officer, Prairies Economic Development Canada (PrairiesCan)
Voyageur Pharmaceuticals would like to engage with the Government of Canada to explore federal programs, grants, and investment incentives that would support the company's continued operations and growth in Alberta. Discussion may include opportunities to enhance the competitiveness of the company's Canadian footprint and to identify federal measures that would help retain jobs, innovation capacity, and long-term investment in Canada. Read more
-
Reported by Brian Senio · Consultant
- Benoit Leduc · Manager, Life Sciences Directorate, Innovation, Science and Economic Development Canada (ISED)
- Shanon McAreavy · Senior Business Officer, Prairies Economic Development Canada (PrairiesCan)
Voyageur Pharmaceuticals would like to engage with the Government of Canada to explore federal programs, grants, and investment incentives that would support the company's continued operations and growth in Alberta. Discussion may include opportunities to enhance the competitiveness of the company's Canadian footprint and to identify federal measures that would help retain jobs, innovation capacity, and long-term investment in Canada. Read more
-
Reported by Brian Senio · Consultant
- Benoit Leduc · Manager, Life Sciences Directorate, Innovation, Science and Economic Development Canada (ISED)
- Shanon McAreavy · Senior Business Officer, Prairies Economic Development Canada (PrairiesCan)
Voyageur Pharmaceuticals would like to engage with the Government of Canada to explore federal programs, grants, and investment incentives that would support the company's continued operations and growth in Alberta. Discussion may include opportunities to enhance the competitiveness of the company's Canadian footprint and to identify federal measures that would help retain jobs, innovation capacity, and long-term investment in Canada. Read more
-
Reported by Brian Senio · Consultant
- Benoit Leduc · Manager, Life Sciences Directorate, Innovation, Science and Economic Development Canada (ISED)
Voyageur Pharmaceuticals would like to engage with the Government of Canada to explore federal programs, grants, and investment incentives that would support the company's continued operations and growth in Alberta. Discussion may include opportunities to enhance the competitiveness of the company's Canadian footprint and to identify federal measures that would help retain jobs, innovation capacity, and long-term investment in Canada. Read more
-
Reported by Brian Senio · Consultant
- Sana Mehrani · Senior Policy Analyst, Innovation, Science and Economic Development Canada (ISED)
- Razan Shahin · Sector Analyst, Innovation, Science and Economic Development Canada (ISED)
- Benoit Leduc · Manager, Life Sciences Directorate, Innovation, Science and Economic Development Canada (ISED)
Voyageur Pharmaceuticals would like to engage with the Government of Canada to explore federal programs, grants, and investment incentives that would support the company's continued operations and growth in Alberta. Discussion may include opportunities to enhance the competitiveness of the company's Canadian footprint and to identify federal measures that would help retain jobs, innovation capacity, and long-term investment in Canada. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.